$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

$sbra Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000149229823000025 Filed on November 06, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$163.4M	$161.6M
YoY Change	-0.96%	14.82%
Cost Of Revenue	$45.19M	$44.52M
YoY Change	15.41%	21.3%
Gross Profit	$118.2M	$117.1M
YoY Change	-6.06%	12.54%
Gross Profit Margin	72.34%	72.45%
Selling, General & Admin	$16.32M	$11.09M
YoY Change	48.29%	17.21%
% of Gross Profit	13.81%	9.47%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$42.88M	$43.24M
YoY Change	-14.12%	-8.82%
% of Gross Profit	36.27%	36.93%
Operating Expenses	$63.89M	$58.63M
YoY Change	-2.57%	-5.44%
Operating Profit	$54.32M	$58.47M
YoY Change	-9.85%	39.04%
Interest Expense	-$28.70M	-$28.80M
YoY Change	-75.3%	-8.44%
% of Operating Profit	-52.83%	-49.26%
Other Income/Expense, Net	$28.00K	-$44.32M
YoY Change	-114.29%	-5825.58%
Pretax Income	$17.65M	-$14.00M
YoY Change	-120.81%	-68.96%
Income Tax	$493.0K	$455.0K
% Of Pretax Income	2.79%
Net Earnings	$17.16M	-$15.10M
YoY Change	-120.2%	-69.84%
Net Earnings / Revenue	10.5%	-9.34%
Basic Earnings Per Share		-$0.07
Diluted Earnings Per Share	$0.07	-$0.07
COMMON SHARES
Basic Shares Outstanding	231.2M shares	231.2M shares
Diluted Shares Outstanding		231.2M shares

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$41.29M	$33.26M
YoY Change	-16.27%	26.5%
Cash & Equivalents	$41.29M	$33.26M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$175.1M	$185.5M
YoY Change	-11.22%	6.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.617B	$4.603B
YoY Change	-6.9%	-8.29%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$136.8M	$135.8M
YoY Change	1.39%	-34.61%
Other Assets	$5.434M	$5.602M
YoY Change	17.52%	15.29%
Total Long-Term Assets	$5.211B	$5.195B
YoY Change	-6.11%	-8.38%
TOTAL ASSETS
Total Short-Term Assets	$175.1M	$185.5M
Total Long-Term Assets	$5.211B	$5.195B
Total Assets	$5.386B	$5.381B
YoY Change	-6.29%	-7.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$120.5M	$106.9M
YoY Change	-2.88%	-13.21%
Accrued Expenses	$16.50M	$21.10M
YoY Change	-9.34%	-4.09%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$137.0M	$128.0M
YoY Change	-3.71%	-11.83%
LONG-TERM LIABILITIES
Long-Term Debt	$2.414B	$2.349B
YoY Change	-3.7%	-3.98%
Other Long-Term Liabilities	$32.53M	$34.19M
YoY Change	-22.99%	-22.33%
Total Long-Term Liabilities	$2.447B	$2.384B
YoY Change	-4.02%	-4.31%
TOTAL LIABILITIES
Total Short-Term Liabilities	$137.0M	$128.0M
Total Long-Term Liabilities	$2.447B	$2.384B
Total Liabilities	$2.584B	$2.512B
YoY Change	-4.0%	-4.72%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.313M	$2.312M
YoY Change	0.13%	0.09%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$2.803B	$2.869B
YoY Change
Total Liabilities & Shareholders Equity	$5.386B	$5.381B
YoY Change	-6.29%	-7.94%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	$17.16M	-$15.10M
YoY Change	-120.2%	-69.84%
Depreciation, Depletion And Amortization	$42.88M	$43.24M
YoY Change	-14.12%	-8.82%
Cash From Operating Activities	$78.74M	$83.22M
YoY Change	16.5%	-23.28%
INVESTING ACTIVITIES
Capital Expenditures	$38.90M	$0.00
YoY Change	373.29%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	-$22.88M	$59.93M
YoY Change	-0.27%	833.01%
Cash From Investing Activities	-$61.78M	$59.93M
YoY Change	98.26%	-205.16%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-9.363M	-136.4M
YoY Change	-30.74%	48.87%
NET CHANGE
Cash From Operating Activities	78.74M	83.22M
Cash From Investing Activities	-61.78M	59.93M
Cash From Financing Activities	-9.363M	-136.4M
Net Change In Cash	7.595M	6.750M
YoY Change	-66.85%	-116.81%
FREE CASH FLOW
Cash From Operating Activities	$78.74M	$83.22M
Capital Expenditures	$38.90M	$0.00
Free Cash Flow	$39.84M	$83.22M
YoY Change	-32.9%	-51.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Entity Central Index Key EntityCentralIndexKey	0001492298
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Type Of Revenue Extensible List TypeOfRevenueExtensibleList	http://fasb.org/us-gaap/2023#HealthCareResidentServiceMember
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	40131000	usd
CY2022Q4	sbra	Accounts Receivable Prepaid Expenses Deferred Financing Costs And Other Assets Net AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet	147908000	usd
CY2022Q4	us-gaap	Assets Assets	5747672000	usd
CY2022Q4	us-gaap	Secured Debt SecuredDebt	49232000	usd
CY2022Q4	us-gaap	Line Of Credit LineOfCredit	196982000	usd
CY2022Q4	us-gaap	Loans Payable To Bank LoansPayableToBank	526129000	usd
CY2022Q4	us-gaap	Unsecured Debt UnsecuredDebt	1734431000	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	142259000	usd
CY2022Q4	us-gaap	Below Market Lease Net BelowMarketLeaseNet	42244000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	2691277000	usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	231009295	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2310000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4486967000	usd
CY2022Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1451945000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	3056395000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133973000	usd
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	28585000	usd
	us-gaap	Revenues Revenues	459826000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	137855000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-411000	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-1101000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	-4581000	usd
	sbra	Income Loss From Equity Method Investments And Other Than Temporary Impairment IncomeLossFromEquityMethodInvestmentsAndOtherThanTemporaryImpairment	-9715000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1118000	usd
	us-gaap	Net Income Loss NetIncomeLoss	7343000	usd
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230936032	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	231779750	shares
	us-gaap	Net Income Loss NetIncomeLoss	7343000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	3505000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	28543000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	35886000	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	3317726000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-50064000	usd
CY2022Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	8377000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2657000	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	-127000	usd
CY2022Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
CY2022Q3	us-gaap	Dividends Common Stock DividendsCommonStock	69836000	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	3208733000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	2943744000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-15101000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7430000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2900000	usd
	sbra	Payments For Escrow Deposits For Potential Investments PaymentsForEscrowDepositsForPotentialInvestments	0	usd
	sbra	Payments For Escrow Deposits For Potential Investments PaymentsForEscrowDepositsForPotentialInvestments	836000	usd
	sbra	Repayments Of Preferred Equity Investments RepaymentsOfPreferredEquityInvestments	-4828000	usd
	sbra	Repayments Of Preferred Equity Investments RepaymentsOfPreferredEquityInvestments	-4173000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	4797000	usd
	us-gaap	Payments To Acquire Interest In Joint Venture PaymentsToAcquireInterestInJointVenture	128019000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	248222000	usd
	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	62816000	usd
	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	25490000	usd
	us-gaap	Proceeds From Lease Payment Sales Type And Direct Financing Leases Investing Activity ProceedsFromLeasePaymentSalesTypeAndDirectFinancingLeasesInvestingActivity	0	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6611000	usd
CY2023Q3	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://www.sabrahealth.com/20230930#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank
CY2022Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent http://fasb.org/us-gaap/2023#LineOfCredit http://fasb.org/us-gaap/2023#LoansPayableToBank
CY2023Q3	us-gaap	Derivative Asset Statement Of Financial Position Extensible Enumeration DerivativeAssetStatementOfFinancialPositionExtensibleEnumeration	http://www.sabrahealth.com/20230930#AccountsReceivablePrepaidExpensesDeferredFinancingCostsAndOtherAssetsNet
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 550
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	false
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	231219523	shares
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2022Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	411396000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	134962000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49308000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	4624000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	19063000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5747672000	usd
	us-gaap	Operating Lease Lease Income OperatingLeaseLeaseIncome	297268000	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	77573000	usd
	sbra	Operating And Interest Expense OperatingAndInterestExpense	435557000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-6093000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	18176000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	25038000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	8674000	usd
	us-gaap	Proceeds From Collection Of Notes Receivable ProceedsFromCollectionOfNotesReceivable	4885000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	6001000	usd
	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	0	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	544000	usd
	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	164909000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-185088000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	-165338000	usd
	us-gaap	Proceeds From Repayments Of Lines Of Credit ProceedsFromRepaymentsOfLinesOfCredit	147353000	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	12188000	usd
	us-gaap	Proceeds From Issuance Of Medium Term Notes ProceedsFromIssuanceOfMediumTermNotes	0	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	0	usd
	us-gaap	Repayments Of Medium Term Notes RepaymentsOfMediumTermNotes	63750000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1479000	usd
	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	17030000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	18135000	usd
	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	6000	usd
	us-gaap	Payments Of Dividends PaymentsOfDividends	208079000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-400937000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-148188000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-14194000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-85130000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-880000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	392000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	53932000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	115886000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38858000	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	31148000	usd
	us-gaap	Interest Paid Net InterestPaidNet	72911000	usd
	us-gaap	Interest Paid Net InterestPaidNet	68778000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	4644000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Net Nonmonetary Assets Acquired Liabilities Assumed1 NoncashOrPartNoncashAcquisitionNetNonmonetaryAssetsAcquiredLiabilitiesAssumed1	14311000	usd
CY2023Q3	sbra	Real Estate Investments Joint Ventures Number RealEstateInvestmentsJointVenturesNumber	0	investment
	us-gaap	Use Of Estimates UseOfEstimates	The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. Actual results could materially differ from those estimates.
CY2023Q3	sbra	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	1508364000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	3016247000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	44000000	usd
CY2023Q3	us-gaap	Equity Method Investments EquityMethodInvestments	135755000	usd
CY2023Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5605498000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1002484000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4603014000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2023Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	4815199000	usd
CY2022Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5034470000	usd
CY2023Q3	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	234882000	usd
CY2022Q4	us-gaap	Fixtures And Equipment Gross FixturesAndEquipmentGross	262644000	usd
CY2023Q3	us-gaap	Land Improvements LandImprovements	10241000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	7085000	usd
CY2023Q3	us-gaap	Land Land	545176000	usd
CY2022Q4	us-gaap	Land Land	568489000	usd
CY2023Q3	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5605498000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	5872688000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	1002484000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	913345000	usd
CY2023Q3	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4603014000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	4959343000	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y
CY2023Q3	us-gaap	Security Deposit Liability SecurityDepositLiability	17000000	usd
CY2022Q4	us-gaap	Security Deposit Liability SecurityDepositLiability	13000000	usd
CY2023Q3	sbra	Letters Of Credit Deposits LettersOfCreditDeposits	57000000	usd
CY2022Q4	sbra	Letters Of Credit Deposits LettersOfCreditDeposits	57000000	usd
CY2023Q3	sbra	Property Taxes Insurance And Tenant Improvement Deposit Liability PropertyTaxesInsuranceAndTenantImprovementDepositLiability	11600000	usd
CY2022Q4	sbra	Property Taxes Insurance And Tenant Improvement Deposit Liability PropertyTaxesInsuranceAndTenantImprovementDepositLiability	13300000	usd
CY2023Q3	us-gaap	Variable Lease Income VariableLeaseIncome	3800000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	11400000	usd
CY2022Q3	us-gaap	Variable Lease Income VariableLeaseIncome	4300000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	13700000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	91919000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	371661000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	366190000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	350583000	usd
CY2023Q3	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	327530000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	134962000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	7100000	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	72600000	usd
	sbra	Disposal Group Including Discontinued Operations Number Of Properties DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties	27	facility
	sbra	Disposal Group Including Discontinued Operations Number Of Properties DisposalGroupIncludingDiscontinuedOperationsNumberOfProperties	11	facility
CY2023Q3	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	256200000	usd
CY2022Q3	us-gaap	Disposal Group Including Discontinued Operation Consideration DisposalGroupIncludingDiscontinuedOperationConsideration	62800000	usd
CY2023Q3	sbra	Disposal Group Including Discontinued Operation Assets And Liabilities Net DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet	332100000	usd
CY2022Q3	sbra	Disposal Group Including Discontinued Operation Assets And Liabilities Net DisposalGroupIncludingDiscontinuedOperationAssetsAndLiabilitiesNet	67400000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-75900000	usd
	us-gaap	Disposal Group Not Discontinued Operation Gain Loss On Disposal DisposalGroupNotDiscontinuedOperationGainLossOnDisposal	-4600000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-80300000	usd
	us-gaap	Disposal Group Including Discontinued Operation Operating Income Loss DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss	-63100000	usd
	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	7100000	usd
	us-gaap	Disposal Group Not Discontinued Operation Loss Gain On Write Down DisposalGroupNotDiscontinuedOperationLossGainOnWriteDown	65800000	usd
CY2023Q3	sbra	Financing Receivable Number Of Loans FinancingReceivableNumberOfLoans	12	loan
CY2023Q3	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	371133000	usd
CY2023Q3	us-gaap	Notes Receivable Gross NotesReceivableGross	367703000	usd
CY2022Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	366936000	usd
CY2023Q3	sbra	Financing Receivable Fixed Interest Rate FinancingReceivableFixedInterestRate	0.076
CY2023Q3	sbra	Financing Receivable Effective Interest Rate FinancingReceivableEffectiveInterestRate	0.076
CY2023Q3	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6677000	usd
CY2023Q3	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	371133000	usd
CY2023Q3	us-gaap	Notes Receivable Net NotesReceivableNet	361026000	usd
CY2022Q4	us-gaap	Notes Receivable Net NotesReceivableNet	360325000	usd
CY2023Q3	sbra	Preferred Equity Investments Number PreferredEquityInvestmentsNumber	5	preferredequityinvestment
CY2023Q3	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	56760000	usd
CY2023Q3	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	56921000	usd
CY2022Q4	sbra	Preferred Equity Investment Carrying Amount PreferredEquityInvestmentCarryingAmount	51071000	usd
CY2023Q3	sbra	Preferred Equity Investment Weighted Average Contractual Rate PreferredEquityInvestmentWeightedAverageContractualRate	0.110
CY2023Q3	sbra	Preferred Equity Investment Weighted Average Effective Rate PreferredEquityInvestmentWeightedAverageEffectiveRate	0.110
CY2023Q3	sbra	Number Of Investments NumberOfInvestments	17	investment
CY2023Q3	us-gaap	Investment Owned Balance Principal Amount InvestmentOwnedBalancePrincipalAmount	427893000	usd
CY2023Q3	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	417947000	usd
CY2022Q4	sbra	Financing Receivable And Other Investments Net FinancingReceivableAndOtherInvestmentsNet	411396000	usd
CY2023Q3	sbra	Investments Weighted Average Contractual Rate InvestmentsWeightedAverageContractualRate	0.081
CY2023Q3	sbra	Investments Weighted Average Effective Rate InvestmentsWeightedAverageEffectiveRate	0.080
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6611000	usd
CY2021Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	6344000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	549000	usd
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	83000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	483000	usd
	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
	us-gaap	Interest Expense Debt InterestExpenseDebt	77600000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	8300000	usd
CY2022Q4	us-gaap	Interest Payable Current And Noncurrent InterestPayableCurrentAndNoncurrent	18200000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	499000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	2034000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	2089000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	502147000	usd
CY2023Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	134829000	usd
CY2023Q3	sbra	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	1730128000	usd
CY2023Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	2371726000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	4075000	usd
CY2023Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	18173000	usd
CY2023Q3	us-gaap	Long Term Debt LongTermDebt	2349478000	usd
	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax	26426000	usd
	sbra	Other Comprehensive Income Loss Cash Flow And Net Investment Hedge Gain Loss Before Reclassification And Tax OtherComprehensiveIncomeLossCashFlowAndNetInvestmentHedgeGainLossBeforeReclassificationAndTax	41606000	usd
CY2023Q3	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	371133000	usd
CY2022Q4	sbra	Financing Receivable Principal Amount FinancingReceivablePrincipalAmount	370364000	usd
CY2023Q3	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	56760000	usd
CY2022Q4	sbra	Preferred Equity Investment Face Value PreferredEquityInvestmentFaceValue	50902000	usd
CY2023Q3	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.30
	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3300000	usd
	us-gaap	Net Income Loss NetIncomeLoss	7343000	usd
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	230936032	shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	843718	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	231779750	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.03
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.03

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
sbra-20230930_lab.xml	Edgar Link	unprocessable
0001492298-23-000025-index-headers.html	Edgar Link	pending
0001492298-23-000025-index.html	Edgar Link	pending
0001492298-23-000025.txt	Edgar Link	pending
0001492298-23-000025-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
sbra-20230930.htm	Edgar Link	pending
sbra-20230930.xsd	Edgar Link	pending
sbraex3112023q3.htm	Edgar Link	pending
sbraex3122023q3.htm	Edgar Link	pending
sbraex3212023q3.htm	Edgar Link	pending
sbraex3222023q3.htm	Edgar Link	pending
Show.js	Edgar Link	pending
sbra-20230930_cal.xml	Edgar Link	unprocessable
sbra-20230930_def.xml	Edgar Link	unprocessable
sbra-20230930_pre.xml	Edgar Link	unprocessable
sbra-20230930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra

2023 Q4 Form 10-Q Financial Statement

#000149229823000025 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA Sabra Health Care REIT, Inc. Stock $sbra

2023 Q4 Form 10-Q Financial Statement

#000149229823000025 Filed on November 06, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SBRA
Sabra Health Care REIT, Inc. Stock $sbra